B. Philippe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
B. Philippe has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- L J Couderc
Service de Pneumologie, Hôpital Foch, Suresnes, France
2 shared publications - Patrick Honderlick
Service de Microbiologie, Hôpital Foch, Suresnes, France
2 shared publications A Scherrer
1 shared publication- Alain Chapelier
Department of Thoracic Surgery and Lung Transplantation , Hôpital Foch , Suresnes , France
1 shared publication B. Dupont
Department of Infectious Diseases, Necker Hospital, Paris, France
1 shared publicationC. Picard
Department of Pulmonary Diseases, Saint Louis Hospital, Paris, France
1 shared publication
Latest Publications
- 11 January 2010
- Published by Wiley in Transplant Infectious Disease
- Vol. 12 (3) , 273-276
Severe Aspergillus endocarditis in a lung transplant recipient with a five-year survival
We report the case of a patient with cystic fibrosis who underwent lung transplant and developed Aspergillus endocarditis and cutaneous relapse. Long-term survival was achieved with surgical and prolonged antifungal treatment. This case report emphasizes the recommendation of life-long antifungal treatment in transplant recipients who survive an episode of fungal endocarditis.
- 11 January 2010
- Published by Wiley in Transplant Infectious Disease
- Vol. 12 (3) , 273-276
Severe Aspergillus endocarditis in a lung transplant recipient with a five-year survival
We report the case of a patient with cystic fibrosis who underwent lung transplant and developed Aspergillus endocarditis and cutaneous relapse. Long-term survival was achieved with surgical and prolonged antifungal treatment. This case report emphasizes the recommendation of life-long antifungal treatment in transplant recipients who survive an episode of fungal endocarditis.
- 1 February 2007
- Vol. 24 (2) , 145-54
[Management of the pulmonary complications of haematological malignancy].
The high frequency of pulmonary complications of haematological malignancy and the increasing number of patients treated for these disorders make it important that the respiratory physician has a structured diagnostic approach according to: 1 the immune deficiency due to the malignancy and/or the treatment administered; 2 the factors that can modify the risk of infection (anti infection prophylaxis and/or pre-emptive treatment); 3 co-morbidities; 4 extra-pulmonary manifestations. Two main situations can be identified: The patient is aplasic: Initially the pneumonias are predominantly of bacterial origin but may be fungal if the neutropenia is prolonged. The respiratory physician is faced with two problems: 1 the diagnosis of pneumonia; this may be helped by CT scanning; 2 The choice of antibiotics; this will depend on previous investigations. The patient is not aplasic: The lung disease may have many causes, mainly infectious but also drug related, tumoral, haemorrhagic or embolic. The main problem is the correct choice of investigations to establish an aetiological diagnosis. The collection of data according to a pre-established protocol based on simple factors (study of the notes and clinical examination) is one of the key elements for improving the prognosis of these patients whose management should be multidisciplinary following a pre-defined plan.
- 1 February 2007
- Vol. 24 (2) , 145-54
[Management of the pulmonary complications of haematological malignancy].
The high frequency of pulmonary complications of haematological malignancy and the increasing number of patients treated for these disorders make it important that the respiratory physician has a structured diagnostic approach according to: 1 the immune deficiency due to the malignancy and/or the treatment administered; 2 the factors that can modify the risk of infection (anti infection prophylaxis and/or pre-emptive treatment); 3 co-morbidities; 4 extra-pulmonary manifestations. Two main situations can be identified: The patient is aplasic: Initially the pneumonias are predominantly of bacterial origin but may be fungal if the neutropenia is prolonged. The respiratory physician is faced with two problems: 1 the diagnosis of pneumonia; this may be helped by CT scanning; 2 The choice of antibiotics; this will depend on previous investigations. The patient is not aplasic: The lung disease may have many causes, mainly infectious but also drug related, tumoral, haemorrhagic or embolic. The main problem is the correct choice of investigations to establish an aetiological diagnosis. The collection of data according to a pre-established protocol based on simple factors (study of the notes and clinical examination) is one of the key elements for improving the prognosis of these patients whose management should be multidisciplinary following a pre-defined plan.
- 31 January 2006
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 23, 53
Aspergillose pulmonaire du malade non neutropénique et antigénémie aspergillaire
- 31 January 2006
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 23, 53
Aspergillose pulmonaire du malade non neutropénique et antigénémie aspergillaire
- 31 January 2006
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 23, 116
Étude du killing d’Aspergillus fumigatus par les macrophages alvéolaires de transplantés pulmonaires
- 31 January 2006
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 23, 116
Étude du killing d’Aspergillus fumigatus par les macrophages alvéolaires de transplantés pulmonaires